data_1jv9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jv9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.868 -0.419 . . . . 2.3900000000000001 109.868 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.505 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 40.5 Cg_endo -68.07 165.89 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.839 1.441 . . . . 1.02 110.754 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -20.92 16.15 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.003 -0.679 . . . . 1.73 109.896 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 19.6 p90 -66.89 -18.01 65.17 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 118.863 -1.135 . . . . 0.75 110.419 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.416 ' HA ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -84.63 -24.34 29.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 1.27 109.656 179.099 -103.265 149.56 74.76 103.933 2.015 103.745 168.976 -54.522 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.0 mt -74.85 -26.56 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 1.3600000000000001 109.603 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.14 164.71 59.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.726 . . . . 1.95 110.123 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.72 167.01 27.72 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.751 1.395 . . . . 0.52000000000000002 110.232 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.0 Cg_endo -70.94 172.31 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.762 1.401 . . . . 0.46999999999999997 110.394 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -128.08 93.91 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.37 -0.831 . . . . 1.3999999999999999 110.711 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.07 -22.98 66.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.378 -0.971 . . . . 1.1200000000000001 108.378 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.44 176.46 0.66 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.527 -1.429 . . . . 0.47999999999999998 109.527 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -73.3 -117.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.708 1.372 . . . . 1.6599999999999999 109.827 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 m 52.34 -179.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.756 -1.215 . . . . 1.53 110.639 179.892 -85.14 124.545 144.248 104.121 2.019 104.069 -139.497 58.645 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -129.38 4.55 5.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 3.6299999999999999 110.54 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.76 166.74 21.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.165 -0.959 . . . . 1.21 110.047 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.74 72.87 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 4.0099999999999998 110.183 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 82.6 mt -93.88 150.56 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.428 -0.795 . . . . 1.3700000000000001 110.102 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 19' ' ' ILE . 48.7 mm -95.57 84.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.427 -0.796 . . . . 1.25 110.028 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.414 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 2.0 mmt85 -85.9 172.96 10.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 2.5099999999999998 110.202 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -112.38 151.62 29.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 1.1100000000000001 110.803 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.1 p90 -149.6 157.73 43.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.524 -0.735 . . . . 0.28000000000000003 109.581 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -83.84 115.19 22.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.408 -0.807 . . . . 1.01 110.89 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -89.77 95.65 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.68000000000000005 109.575 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.58 -25.53 10.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.336 -0.853 . . . . 1.2 109.93 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -77.5 -24.48 50.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.492 -0.755 . . . . 3.3799999999999999 109.692 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.71 -25.01 16.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.9 . . . . 1.1499999999999999 110.467 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.06 -8.2 76.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.855 -1.298 . . . . 0.53000000000000003 109.855 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.3 -143.9 0.17 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.244 -1.151 . . . . 2.1299999999999999 109.414 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 94.7 m -119.41 157.23 28.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.56000000000000005 110.814 -179.928 -65.133 -117.268 -78.438 104.0 2.02 103.954 -103.513 177.573 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -140.32 176.94 8.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.641 -0.662 . . . . 1.1200000000000001 109.321 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 3.3 p -99.14 144.47 28.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 1.1699999999999999 110.526 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.0 p90 -141.47 164.2 30.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.25 110.31 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -75.38 122.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 1.1100000000000001 110.214 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 8.5 t80 -103.57 145.08 30.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.422 -0.798 . . . . 0.80000000000000004 110.14 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -86.44 1.11 87.31 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.679 -0.969 . . . . 0.34000000000000002 110.679 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 68.44 5.83 5.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.144 -1.209 . . . . 1.1899999999999999 111.321 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -150.06 158.34 44.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.82 -1.175 . . . . 0.81999999999999995 110.526 179.573 58.645 -139.497 144.248 104.069 2.019 104.121 124.545 -85.14 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 50.89 40.73 25.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 2.8399999999999999 110.482 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . . . -67.45 153.51 43.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.427 -0.796 . . . . 1.28 110.358 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -117.01 -166.09 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 2.29 109.566 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HD2' ' CD2' ' A' ' 4' ' ' PHE . 4.9 mtm-85 -75.03 -16.82 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.901 . . . . 3.25 109.458 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 5' ' ' CYS . 2.5 t-20 -92.37 54.23 2.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.2 109.396 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.51 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.4 t-20 -159.29 81.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.884 -0.784 . . . . 0.34999999999999998 108.884 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 37.0 m-85 -91.83 140.92 29.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.445 -0.784 . . . . 0.41999999999999998 110.743 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -65.01 -27.99 69.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.481 -0.762 . . . . 3.7200000000000002 110.401 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -140.37 157.51 45.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.96999999999999997 110.279 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -25.84 68.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 1.3 109.861 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.98 -31.78 66.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.429 -0.795 . . . . 2.1899999999999999 109.899 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -75.77 -31.42 59.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 1.9299999999999999 109.133 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 40.5 t -74.77 -44.07 51.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.123 -0.695 . . . . 0.46999999999999997 109.123 178.961 177.573 -103.513 -78.438 103.954 2.02 104.0 -117.268 -65.133 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -72.71 -42.2 64.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.705 . . . . 1.9399999999999999 109.992 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -64.84 -14.01 57.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.939 . . . . 2.9300000000000002 110.046 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.3 m -98.01 -55.92 2.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 1.2 110.365 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 57.8 m -106.11 -13.47 15.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.837 . . . . 1.52 111.117 -179.056 -54.522 168.976 74.76 103.745 2.015 103.933 149.56 -103.265 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -51.67 141.85 22.11 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.909 -1.276 . . . . 2.1600000000000001 109.909 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.24 53.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.445 -1.462 . . . . 3.0699999999999998 109.445 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.419 -1.048 . . . . 3.6600000000000001 110.219 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.868 -0.419 . . . . 1.99 109.868 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.508 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 40.5 Cg_endo -68.07 165.89 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.839 1.441 . . . . 0.93999999999999995 110.754 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -20.92 16.15 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.003 -0.679 . . . . 1.73 109.896 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 19.6 p90 -66.89 -18.01 65.17 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 118.863 -1.135 . . . . 0.64000000000000001 110.419 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HA ' HD22 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -84.63 -24.34 29.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 1.27 109.656 179.099 -103.265 149.56 74.76 103.933 2.015 103.745 168.976 -54.522 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 45.0 mt -74.85 -26.56 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.64000000000000001 109.603 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.14 164.71 59.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.726 . . . . 1.95 110.123 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.72 167.01 27.72 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.751 1.395 . . . . 0.46000000000000002 110.232 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.0 Cg_endo -70.94 172.31 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.762 1.401 . . . . 0.46999999999999997 110.394 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -128.08 93.91 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.37 -0.831 . . . . 1.0700000000000001 110.711 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.07 -22.98 66.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.378 -0.971 . . . . 0.42999999999999999 108.378 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.44 176.46 0.66 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.527 -1.429 . . . . 0.46999999999999997 109.527 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -73.3 -117.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.708 1.372 . . . . 1.6599999999999999 109.827 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 6.7 m 52.34 -179.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.756 -1.215 . . . . 0.85999999999999999 110.639 179.892 -85.14 124.545 144.248 104.121 2.019 104.069 -139.497 58.645 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -129.38 4.55 5.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 3.1499999999999999 110.54 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.76 166.74 21.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.165 -0.959 . . . . 0.55000000000000004 110.047 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.74 72.87 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 3.3700000000000001 110.183 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.625 HG21 HH21 ' A' ' 20' ' ' ARG . 82.6 mt -93.88 150.56 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.428 -0.795 . . . . 0.72999999999999998 110.102 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.57 84.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.427 -0.796 . . . . 0.62 110.028 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.625 HH21 HG21 ' A' ' 18' ' ' ILE . 2.0 mmt85 -85.9 172.96 10.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 1.95 110.202 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -112.38 151.62 29.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.51000000000000001 110.803 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.1 p90 -149.6 157.73 43.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.524 -0.735 . . . . 0.23999999999999999 109.581 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -83.84 115.19 22.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.408 -0.807 . . . . 0.56000000000000005 110.89 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 54.2 t-20 -89.77 95.65 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.63 109.575 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -52.58 -25.53 10.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.336 -0.853 . . . . 0.53000000000000003 109.93 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -77.5 -24.48 50.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.492 -0.755 . . . . 2.9300000000000002 109.692 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -95.71 -25.01 16.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.9 . . . . 0.56999999999999995 110.467 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.06 -8.2 76.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.855 -1.298 . . . . 0.48999999999999999 109.855 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -138.3 -143.9 0.17 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.244 -1.151 . . . . 1.54 109.414 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 94.7 m -119.41 157.23 28.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.56000000000000005 110.814 -179.928 -65.133 -117.268 -78.438 104.0 2.02 103.954 -103.513 177.573 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -140.32 176.94 8.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.641 -0.662 . . . . 1.1200000000000001 109.321 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 3.3 p -99.14 144.47 28.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.46000000000000002 110.526 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.515 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.0 p90 -141.47 164.2 30.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.20999999999999999 110.31 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -75.38 122.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.41999999999999998 110.214 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.89 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 8.5 t80 -103.57 145.08 30.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.422 -0.798 . . . . 0.34999999999999998 110.14 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -86.44 1.11 87.31 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.679 -0.969 . . . . 0.34000000000000002 110.679 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 68.44 5.83 5.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.144 -1.209 . . . . 0.57999999999999996 111.321 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -150.06 158.34 44.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.82 -1.175 . . . . 0.81999999999999995 110.526 179.573 58.645 -139.497 144.248 104.069 2.019 104.121 124.545 -85.14 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 50.89 40.73 25.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 2.3100000000000001 110.482 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.89 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -67.45 153.51 43.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.427 -0.796 . . . . 0.69999999999999996 110.358 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -117.01 -166.09 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.79 109.566 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HD2' ' CD2' ' A' ' 4' ' ' PHE . 4.9 mtm-85 -75.03 -16.82 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.901 . . . . 2.6899999999999999 109.458 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 5' ' ' CYS . 2.5 t-20 -92.37 54.23 2.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.2 109.396 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.51 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.4 t-20 -159.29 81.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.884 -0.784 . . . . 0.34999999999999998 108.884 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 37.0 m-85 -91.83 140.92 29.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.445 -0.784 . . . . 0.37 110.743 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -65.01 -27.99 69.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.481 -0.762 . . . . 3.2000000000000002 110.401 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -140.37 157.51 45.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.5 110.279 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -25.84 68.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.62 109.861 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.98 -31.78 66.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.429 -0.795 . . . . 2.1899999999999999 109.899 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 48.6 t0 -75.77 -31.42 59.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 1.9299999999999999 109.133 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.424 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 40.5 t -74.77 -44.07 51.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.123 -0.695 . . . . 0.46999999999999997 109.123 178.961 177.573 -103.513 -78.438 103.954 2.02 104.0 -117.268 -65.133 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -72.71 -42.2 64.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.705 . . . . 1.51 109.992 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -64.84 -14.01 57.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.939 . . . . 2.4300000000000002 110.046 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.3 m -98.01 -55.92 2.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.58999999999999997 110.365 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 57.8 m -106.11 -13.47 15.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.837 . . . . 1.52 111.117 -179.056 -54.522 168.976 74.76 103.745 2.015 103.933 149.56 -103.265 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -51.67 141.85 22.11 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.909 -1.276 . . . . 2.1600000000000001 109.909 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.24 53.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.445 -1.462 . . . . 2.9900000000000002 109.445 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.419 -1.048 . . . . 3.6600000000000001 110.219 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.868 -0.419 . . . . 1.99 109.868 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.508 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 40.5 Cg_endo -68.07 165.89 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.839 1.441 . . . . 0.93999999999999995 110.754 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -20.92 16.15 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.003 -0.679 . . . . 1.73 109.896 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 19.6 p90 -66.89 -18.01 65.17 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 118.863 -1.135 . . . . 0.64000000000000001 110.419 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HA ' HD22 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -84.63 -24.34 29.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 1.27 109.656 179.099 -103.265 149.56 74.76 103.933 2.015 103.745 168.976 -54.522 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 45.0 mt -74.85 -26.56 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.64000000000000001 109.603 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.14 164.71 59.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.726 . . . . 1.95 110.123 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.72 167.01 27.72 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.751 1.395 . . . . 0.46000000000000002 110.232 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.0 Cg_endo -70.94 172.31 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.762 1.401 . . . . 0.46999999999999997 110.394 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -128.08 93.91 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.37 -0.831 . . . . 1.0700000000000001 110.711 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.07 -22.98 66.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.378 -0.971 . . . . 0.42999999999999999 108.378 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.44 176.46 0.66 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.527 -1.429 . . . . 0.46999999999999997 109.527 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -73.3 -117.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.708 1.372 . . . . 1.6599999999999999 109.827 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 6.7 m 52.34 -179.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.756 -1.215 . . . . 0.85999999999999999 110.639 179.892 -85.14 124.545 144.248 104.121 2.019 104.069 -139.497 58.645 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -129.38 4.55 5.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 3.1499999999999999 110.54 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.76 166.74 21.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.165 -0.959 . . . . 0.55000000000000004 110.047 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.74 72.87 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 3.3700000000000001 110.183 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.625 HG21 HH21 ' A' ' 20' ' ' ARG . 82.6 mt -93.88 150.56 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.428 -0.795 . . . . 0.72999999999999998 110.102 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.57 84.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.427 -0.796 . . . . 0.62 110.028 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.625 HH21 HG21 ' A' ' 18' ' ' ILE . 2.0 mmt85 -85.9 172.96 10.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 1.95 110.202 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -112.38 151.62 29.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.51000000000000001 110.803 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.1 p90 -149.6 157.73 43.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.524 -0.735 . . . . 0.23999999999999999 109.581 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -83.84 115.19 22.13 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.408 -0.807 . . . . 0.56000000000000005 110.89 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 54.2 t-20 -89.77 95.65 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.63 109.575 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -52.58 -25.53 10.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.336 -0.853 . . . . 0.53000000000000003 109.93 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -77.5 -24.48 50.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.492 -0.755 . . . . 2.9300000000000002 109.692 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -95.71 -25.01 16.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.9 . . . . 0.56999999999999995 110.467 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.06 -8.2 76.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.855 -1.298 . . . . 0.48999999999999999 109.855 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -138.3 -143.9 0.17 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.244 -1.151 . . . . 1.54 109.414 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 94.7 m -119.41 157.23 28.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.56000000000000005 110.814 -179.928 -65.133 -117.268 -78.438 104.0 2.02 103.954 -103.513 177.573 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -140.32 176.94 8.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.641 -0.662 . . . . 1.1200000000000001 109.321 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 3.3 p -99.14 144.47 28.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.46000000000000002 110.526 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.515 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.0 p90 -141.47 164.2 30.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.445 -0.785 . . . . 0.20999999999999999 110.31 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -75.38 122.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.41999999999999998 110.214 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.89 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 8.5 t80 -103.57 145.08 30.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.422 -0.798 . . . . 0.34999999999999998 110.14 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -86.44 1.11 87.31 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.679 -0.969 . . . . 0.34000000000000002 110.679 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 68.44 5.83 5.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.144 -1.209 . . . . 0.57999999999999996 111.321 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -150.06 158.34 44.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.82 -1.175 . . . . 0.81999999999999995 110.526 179.573 58.645 -139.497 144.248 104.069 2.019 104.121 124.545 -85.14 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 50.89 40.73 25.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 2.3100000000000001 110.482 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.89 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -67.45 153.51 43.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.427 -0.796 . . . . 0.69999999999999996 110.358 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -117.01 -166.09 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.79 109.566 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HD2' ' CD2' ' A' ' 4' ' ' PHE . 4.9 mtm-85 -75.03 -16.82 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.901 . . . . 2.6899999999999999 109.458 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 5' ' ' CYS . 2.5 t-20 -92.37 54.23 2.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.2 109.396 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.51 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.4 t-20 -159.29 81.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.884 -0.784 . . . . 0.34999999999999998 108.884 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 37.0 m-85 -91.83 140.92 29.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.445 -0.784 . . . . 0.37 110.743 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -65.01 -27.99 69.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.481 -0.762 . . . . 3.2000000000000002 110.401 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -140.37 157.51 45.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.5 110.279 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -25.84 68.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.62 109.861 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.98 -31.78 66.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.429 -0.795 . . . . 2.1899999999999999 109.899 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 48.6 t0 -75.77 -31.42 59.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 1.9299999999999999 109.133 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.424 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 40.5 t -74.77 -44.07 51.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.123 -0.695 . . . . 0.46999999999999997 109.123 178.961 177.573 -103.513 -78.438 103.954 2.02 104.0 -117.268 -65.133 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -72.71 -42.2 64.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.705 . . . . 1.51 109.992 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -64.84 -14.01 57.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.939 . . . . 2.4300000000000002 110.046 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.3 m -98.01 -55.92 2.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.58999999999999997 110.365 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 57.8 m -106.11 -13.47 15.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.837 . . . . 1.52 111.117 -179.056 -54.522 168.976 74.76 103.745 2.015 103.933 149.56 -103.265 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -51.67 141.85 22.11 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.909 -1.276 . . . . 2.1600000000000001 109.909 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.24 53.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.445 -1.462 . . . . 2.9900000000000002 109.445 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.419 -1.048 . . . . 3.6600000000000001 110.219 -179.951 . . . . . . . . 0 0 . 1 stop_ save_